16 reports

The Genedrive®platform and tuberculosis test are preparing for launch later this year.

  • Tuberculosis
  • India
  • World
  • Epistem Holdings Plc
  • GlobalData's company

Pulmonary Tuberculosis Global Clinical Trials Review, H##, 2016 Reference Code: GDHC##CTIDB Publication Date: AUG 2016 LIST OF TABLES LIST OF FIGURES Pulmonary Tuberculosis Global Clinical Trials Review, H##, 2016 outlines clinical trials in Pulmonary Tuberculosis.

  • Anti-Infective
  • Therapy
  • Tuberculosis
  • World
  • Product Initiative

Our system has the potential to drive major advances in rapid diagnosis of immunologically complex conditions such as tuberculosis. "

  • Diagnostics
  • Tuberculosis
  • United States
  • Company
  • MBio Diagnostics, Inc.

Pretomanid (PA-##) is under investigation for the treatment of pulmonary tuberculosis.

  • Pathology
  • Pharmaceutical
  • Tuberculosis
  • World
  • TB Drug Development, Inc.

Tuberculosis Global Clinical Trials Review, H##, 2016 Reference Code: GDHC##CTIDB Publication Date: FEB 2016 LIST OF TABLES LIST OF FIGURES Tuberculosis Global Clinical Trials Review, H##, 2016 outlines clinical trials in Tuberculosis.

  • Clinical Trial
  • Infectious Disease
  • Tuberculosis
  • World
  • TB Drug Development, Inc.

Tuberculosis Vaccine ## Aeras Enters Into Co-Development Agreement With Infectious Disease Research Institute For ID##/ GLA-SE ## Aeras Enters Into Co-Development Agreement With Tianjin CanSino For Tuberculosis Vaccine ## Aeras Enters Into Co-Development Agreement With China

  • Pathology
  • Tuberculosis
  • Vaccine
  • World
  • M&A

We look forward to working with our counterparts at Aeras to develop new TB vaccines that will help stop tuberculosis in all corners of the world. "

  • Pathology
  • Tuberculosis
  • China
  • Corporate Finance
  • GlobalData's company

Tuberculosis is the biggest infectious disease killer in the world.

  • Medical Supply
  • Tuberculosis
  • United States
  • Company Financials
  • Cepheid

Mycobacterium Tuberculosis Infections Global Clinical Trials Review, H##, 2015 Reference Code: GDHC##CTIDB Publication Date: OCT 2015 LIST OF TABLES LIST OF FIGURES Mycobacterium Tuberculosis Infections Global Clinical Trials Review, H##, 2015 outlines clinical trials in Mycobacter

  • Drug Discovery And Development
  • Tuberculosis
  • World
  • Product Initiative
  • TB Drug Development, Inc.

Global Early development Class II June, 2021 EOSCAPE-TB-DST - Product Description Technology Indication Application Function EOSCAPE Molecular Diagnostics Technology Bacterial Infection Diagnosis Of Bacterial Infection Quantitatively identfies resistance of tuberculosis to rifampicin and fl

  • Genomics
  • Tuberculosis
  • United States
  • Product Initiative
  • GlobalData's company

Global Early development Class II June, 2021 EOSCAPE-TB-DST - Product Description Technology Indication Application Function EOSCAPE Molecular Diagnostics Technology Bacterial Infection Diagnosis Of Bacterial Infection Quantitatively identfies resistance of tuberculosis to rifampicin and fl

  • Genomics
  • Tuberculosis
  • United States
  • Product Initiative
  • GlobalData's company

The company is developing products for the treatment of atopic dermatitis; extensively drug-resistant tuberculosis (XDR)/ multi drug resistant (MDR)/ totally drug resistant (TDR) tuberculosis (TB); asthama and cancer.

  • Healthcare
  • Tuberculosis
  • South Korea
  • Company
  • Qurient Co., Ltd.

The agreement enables FIND, Cepheid and Rutgers to develop next-generation test for mycobacterium tuberculosis.

  • Diagnostics
  • Pharmaceutical
  • Tuberculosis
  • United States
  • GlobalData's company

The company discovers and validates novel biomarkers for tuberculosis.

  • Tuberculosis
  • Australia
  • Company
  • Product Initiative
  • Tyrian Diagnostics Limited

ACCORDING TO THE WORLD HEALTH ORGANIZATION (WHO), TUBERCULOSIS (TB) CONTINUES TO CAUSE SIGNIFICANT MORTALITY AND MORBIDITY THROUGHOUT THE WORLD, RECENTLY SURPASSING HIV AS THE SINGLE LARGEST KILLER OF ALL INFECTIOUS DISEASES.

  • Biosystem
  • Molecular Diagnostic
  • Tuberculosis
  • United States
  • Akonni Biosystems, Inc.

" Proteins are an indirect marker of M. tuberculosis infection activity, " Achkar said.

  • Cancer
  • Pharmaceutical
  • Tuberculosis
  • United States
  • GlobalData's company